Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Antiaging Quantum Living Inc AAQL

Antiaging Quantum Living Inc. is an investment holding company. It focuses on Website development, maintenance and online business advertisement. Its primary business operations are conducted through its subsidiaries AAQL Inc., AAQL HK Limited, Antiaging Doctor Hangzhou Holding LTD (Dao Ling Doctor Hangzhou), Dao Ling Doctor (Zhejiang) Health Management Limited (Dao Ling Doctor Zhejiang), and... see more

Recent & Breaking News (OTCPK:AAQL)

The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas

Benzinga.com  December 19, 2018

45 Biggest Movers From Yesterday

Benzinga.com  December 19, 2018

38 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  December 18, 2018

25 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  December 18, 2018

The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan

Benzinga.com  December 18, 2018

50 Biggest Movers From Yesterday

Benzinga.com  December 18, 2018

4 Stocks Moving In Monday's After-Hours Session

Benzinga.com  December 17, 2018

Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Trials and Provides Clinical Development Strategy Update

GlobeNewswire December 17, 2018

40 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  December 17, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials

Benzinga.com  December 16, 2018

Achillion Interim Clinical Trial Data and Strategic Update Planned for Dec 17th, 2018

GlobeNewswire December 10, 2018

Achillion Reports Third Quarter 2018 Financial Results

GlobeNewswire November 7, 2018

Investor Expectations to Drive Momentum within SunOpta, Acorda Therapeutics, Sapiens International Corporation N.V, The Descartes Systems Group, Achillion Pharmaceuticals, and CSS Industries — Discovering Underlying Factors of Influence

GlobeNewswire October 17, 2018

Achillion to Present at the Leerink Partners Roundtable Series

GlobeNewswire September 25, 2018

Achillion Appoints Paul Firuta Chief Operating Officer

GlobeNewswire September 10, 2018

Achillion to Present at the Baird 2018 Global Healthcare Conference

GlobeNewswire August 30, 2018

Achillion Appoints Dr. Steven Zelenkofske as Chief Medical Officer and Further Strengthens Clinical Development Team

GlobeNewswire August 21, 2018

Recent Analysis Shows Ferroglobe, AXT, ChemoCentryx, RedHill Biopharma, GTx, and Achillion Pharmaceuticals Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire August 20, 2018

Achillion Expands Management Team With Appointment of Anthony S. Gibney as Chief Business Officer

GlobeNewswire August 15, 2018

Achillion Reports Second Quarter 2018 Financial Results

GlobeNewswire August 8, 2018